Tonix Pharma (TNXP) Misses Q2 EPS by 215c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.68), $2.15 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Amneal gets FDA approval for lanreotide injection, launches immediately
• Anthropic delays planned IPO from October to November - WSJ